OMEROS CORP Interest Expense
OMEROS CORP (OMER) reported Interest Expense of $4.05 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-11-13
- OMEROS CORP interest expense for the quarter ending 2024-09-30 was $4.05M, a 48.81% decline year-over-year.
- OMEROS CORP interest expense for the quarter ending 2024-06-30 was $9.21M, a 16.17% increase year-over-year.
- OMEROS CORP interest expense for the quarter ending 2024-03-31 was $8.23M, a 3.76% increase year-over-year.
- OMEROS CORP interest expense for the quarter ending 2023-12-31 was $7.06M, a 10.63% decline year-over-year.
- OMEROS CORP interest expense for fiscal 2023 was $30.84M, a 35.86% increase from fiscal 2022.
- OMEROS CORP interest expense for fiscal 2022 was $22.70M, a 15.42% increase from fiscal 2021.
- OMEROS CORP interest expense for fiscal 2021 was $19.67M, a 26.47% decline from fiscal 2020.
- OMEROS CORP interest expense for fiscal 2020 was $26.75M, a 18.07% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 204 month | Interest Expense 207 month |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $4.05M 10-Q · filed 2024-11-13 | $13.27M derived: sum of 2 quarters · filed 2024-11-13 | $21.50M 10-Q · filed 2024-11-13 | $28.56M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2024-06-30 | $9.21M 10-Q · filed 2024-08-07 | $17.45M 10-Q · filed 2024-08-07 | $24.51M derived: sum of 3 quarters · filed 2024-08-07 | $32.42M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2024-03-31 | $8.23M 10-Q · filed 2024-05-15 | $15.29M derived: sum of 2 quarters · filed 2024-05-15 | $23.21M derived: sum of 3 quarters · filed 2024-11-13 | $31.14M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-12-31 | $7.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $14.98M derived: sum of 2 quarters · filed 2024-11-13 | $22.91M derived: sum of 3 quarters · filed 2024-11-13 | $30.84M 10-K · filed 2024-04-01 | ||||
| 2023-09-30 | $7.92M 10-Q · filed 2024-11-13 | $15.85M derived: sum of 2 quarters · filed 2024-11-13 | $23.78M 10-Q · filed 2024-11-13 | $31.68M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $7.93M 10-Q · filed 2024-08-07 | $15.87M 10-Q · filed 2024-08-07 | $23.77M derived: sum of 3 quarters · filed 2024-08-07 | $28.70M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $7.93M 10-Q · filed 2024-05-15 | $15.84M derived: sum of 2 quarters · filed 2024-05-15 | $20.77M derived: sum of 3 quarters · filed 2024-05-15 | $25.70M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $12.84M derived: sum of 2 quarters · filed 2024-04-01 | $17.76M derived: sum of 3 quarters · filed 2024-04-01 | $22.70M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $4.93M 10-Q · filed 2023-11-09 | $9.86M derived: sum of 2 quarters · filed 2023-11-09 | $14.80M 10-Q · filed 2023-11-09 | $19.75M derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-06-30 | $4.93M 10-Q · filed 2023-08-09 | $9.87M 10-Q · filed 2023-08-09 | $14.82M derived: sum of 3 quarters · filed 2024-04-01 | $19.73M derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-03-31 | $4.94M 10-Q · filed 2023-05-09 | $9.89M derived: sum of 2 quarters · filed 2024-04-01 | $14.80M derived: sum of 3 quarters · filed 2024-04-01 | $19.71M derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2021-12-31 | $4.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $9.86M derived: sum of 2 quarters · filed 2024-04-01 | $14.77M derived: sum of 3 quarters · filed 2024-04-01 | $19.67M 10-K · filed 2024-04-01 | ||||
| 2021-09-30 | $4.91M 10-Q · filed 2022-11-09 | $9.82M derived: sum of 2 quarters · filed 2022-11-09 | $14.72M 10-Q · filed 2022-11-09 | $14.72M 10-Q · filed 2021-11-09 | $22.71M derived: sum of 4 quarters · filed 2023-03-13 | |||
| 2021-06-30 | $4.91M 10-Q · filed 2022-08-09 | $9.81M 10-Q · filed 2022-08-09 | $9.81M 10-Q · filed 2021-08-09 | $17.80M derived: sum of 3 quarters · filed 2023-03-13 | $24.68M derived: sum of 4 quarters · filed 2023-03-13 | |||
| 2021-03-31 | $4.90M 10-Q · filed 2022-05-10 | $12.88M derived: sum of 2 quarters · filed 2023-03-13 | $19.77M derived: sum of 3 quarters · filed 2023-03-13 | $25.75M derived: sum of 4 quarters · filed 2023-03-13 | ||||
| 2020-12-31 | $7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $14.87M derived: sum of 2 quarters · filed 2023-03-13 | $20.85M derived: sum of 3 quarters · filed 2023-03-13 | $26.75M 10-K · filed 2023-03-13 | ||||
| 2020-09-30 | $6.88M 10-Q · filed 2021-11-09 | $12.86M derived: sum of 2 quarters · filed 2021-11-09 | $18.76M 10-Q · filed 2021-11-09 | $24.57M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $5.98M 10-Q · filed 2021-08-09 | $11.88M 10-Q · filed 2021-08-09 | $17.69M derived: sum of 3 quarters · filed 2022-03-01 | $23.41M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $5.90M 10-Q · filed 2021-05-10 | $11.71M derived: sum of 2 quarters · filed 2022-03-01 | $17.43M derived: sum of 3 quarters · filed 2022-03-01 | $22.96M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $5.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $11.53M derived: sum of 2 quarters · filed 2022-03-01 | $17.06M derived: sum of 3 quarters · filed 2022-03-01 | $22.66M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $5.71M 10-Q · filed 2020-11-09 | $11.24M derived: sum of 2 quarters · filed 2020-11-09 | $16.85M 10-Q · filed 2020-11-09 | $21.99M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $5.53M 10-Q · filed 2020-08-10 | $11.13M 10-Q · filed 2020-08-10 | $16.28M derived: sum of 3 quarters · filed 2021-03-01 | $20.88M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $5.60M 10-Q · filed 2020-05-11 | $10.75M derived: sum of 2 quarters · filed 2021-03-01 | $15.35M derived: sum of 3 quarters · filed 2021-03-01 | $19.03M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $5.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $9.75M derived: sum of 2 quarters · filed 2021-03-01 | $13.43M derived: sum of 3 quarters · filed 2021-03-01 | $16.25M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $4.60M 10-Q · filed 2019-11-12 | $8.28M derived: sum of 2 quarters · filed 2019-11-12 | $11.10M 10-Q · filed 2019-11-12 | $13.97M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | $3.68M 10-Q · filed 2019-08-08 | $6.50M 10-Q · filed 2019-08-08 | $9.37M derived: sum of 3 quarters · filed 2020-03-02 | $12.14M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $2.83M 10-Q · filed 2019-05-09 | $5.69M derived: sum of 2 quarters · filed 2020-03-02 | $8.47M derived: sum of 3 quarters · filed 2020-03-02 | $11.19M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $5.64M derived: sum of 2 quarters · filed 2020-03-02 | $8.37M derived: sum of 3 quarters · filed 2020-03-02 | $11.03M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | $2.78M 10-Q · filed 2018-11-08 | $5.50M derived: sum of 2 quarters · filed 2018-11-08 | $8.17M 10-Q · filed 2018-11-08 | $10.62M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $2.72M 10-Q · filed 2018-08-09 | $5.39M 10-Q · filed 2018-08-09 | $7.84M derived: sum of 3 quarters · filed 2019-03-01 | $9.97M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $2.66M 10-Q · filed 2018-05-10 | $5.12M derived: sum of 2 quarters · filed 2019-03-01 | $7.25M derived: sum of 3 quarters · filed 2019-03-01 | $9.11M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $4.59M derived: sum of 2 quarters · filed 2019-03-01 | $6.44M derived: sum of 3 quarters · filed 2019-03-01 | $7.82M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | $2.13M 10-Q · filed 2017-11-09 | $3.99M derived: sum of 2 quarters · filed 2017-11-09 | $5.37M 10-Q · filed 2017-11-09 | $6.17M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $1.86M 10-Q · filed 2017-08-08 | $3.23M 10-Q · filed 2017-08-08 | $4.04M derived: sum of 3 quarters · filed 2018-03-01 | $4.91M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $1.38M 10-Q · filed 2017-05-10 | $2.18M derived: sum of 2 quarters · filed 2018-03-01 | $3.05M derived: sum of 3 quarters · filed 2018-03-01 | $3.99M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $808.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.68M derived: sum of 2 quarters · filed 2018-03-01 | $2.62M derived: sum of 3 quarters · filed 2018-03-01 | $3.57M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $871.00K 10-Q · filed 2016-11-09 | $1.81M derived: sum of 2 quarters · filed 2016-11-09 | $2.77M 10-Q · filed 2016-11-09 | $3.68M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | $937.00K 10-Q · filed 2016-08-09 | $1.89M 10-Q · filed 2016-08-09 | $2.81M derived: sum of 3 quarters · filed 2017-03-16 | $3.75M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $957.00K 10-Q · filed 2016-05-10 | $1.87M derived: sum of 2 quarters · filed 2017-03-16 | $2.82M derived: sum of 3 quarters · filed 2017-03-16 | $3.75M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | $915.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.86M derived: sum of 2 quarters · filed 2017-03-16 | $2.80M derived: sum of 3 quarters · filed 2017-03-16 | $3.47M 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | $944.00K 10-Q · filed 2015-11-09 | $1.88M derived: sum of 2 quarters · filed 2015-11-09 | $2.56M 10-Q · filed 2015-11-09 | $3.15M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | $939.00K 10-Q · filed 2015-08-10 | $1.61M 10-Q · filed 2015-08-10 | $2.21M derived: sum of 3 quarters · filed 2016-03-15 | $2.80M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | $672.00K 10-Q · filed 2015-05-11 | $1.27M derived: sum of 2 quarters · filed 2016-03-15 | $1.86M derived: sum of 3 quarters · filed 2016-03-15 | $2.45M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $598.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $1.19M derived: sum of 2 quarters · filed 2016-03-15 | $1.78M derived: sum of 3 quarters · filed 2016-03-15 | $2.37M 10-K · filed 2016-03-15 | ||||
| 2013-09-30 | $592.00K 10-Q · filed 2014-11-10 | $1.18M derived: sum of 2 quarters · filed 2014-11-10 | $1.77M 10-Q · filed 2014-11-10 | $2.14M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-06-30 | $589.00K 10-Q · filed 2014-08-11 | $1.18M 10-Q · filed 2014-08-11 | $1.54M derived: sum of 3 quarters · filed 2015-03-16 | $1.96M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-03-31 | $587.00K 10-Q · filed 2014-05-12 | $956.00K derived: sum of 2 quarters · filed 2015-03-16 | $1.37M derived: sum of 3 quarters · filed 2015-03-16 | $1.82M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2012-12-31 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $782.00K derived: sum of 2 quarters · filed 2015-03-16 | $1.24M derived: sum of 3 quarters · filed 2015-03-16 | $1.73M 10-K · filed 2015-03-16 | ||||
| 2012-09-30 | $413.00K 10-Q · filed 2013-11-07 | $866.00K derived: sum of 2 quarters · filed 2013-11-07 | $1.36M 10-Q · filed 2013-11-07 | $1.90M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $453.00K 10-Q · filed 2013-08-09 | $947.00K 10-Q · filed 2013-08-09 | $1.48M derived: sum of 3 quarters · filed 2014-03-13 | $2.01M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $494.00K 10-Q · filed 2013-05-09 | $1.03M derived: sum of 2 quarters · filed 2014-03-13 | $1.56M derived: sum of 3 quarters · filed 2014-03-13 | $2.08M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $536.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $1.06M derived: sum of 2 quarters · filed 2014-03-13 | $1.59M derived: sum of 3 quarters · filed 2014-03-13 | $1.88M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $528.00K 10-Q · filed 2012-11-09 | $1.05M derived: sum of 2 quarters · filed 2012-11-09 | $1.35M 10-Q · filed 2012-11-09 | $1.66M derived: sum of 4 quarters · filed 2013-03-18 | $5.71M 10-Q · filed 2011-11-08 | |||
| 2011-06-30 | $527.00K 10-Q · filed 2012-08-07 | $820.00K 10-Q · filed 2012-08-07 | $1.13M derived: sum of 3 quarters · filed 2013-03-18 | $1.49M derived: sum of 4 quarters · filed 2013-03-18 | $5.19M 10-Q · filed 2011-08-09 | |||
| 2011-03-31 | $293.00K 10-Q · filed 2012-05-10 | $605.00K derived: sum of 2 quarters · filed 2013-03-18 | $967.00K derived: sum of 3 quarters · filed 2013-03-18 | $1.38M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2010-12-31 | $312.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $674.00K derived: sum of 2 quarters · filed 2013-03-18 | $1.08M derived: sum of 3 quarters · filed 2013-03-18 | $1.53M 10-K · filed 2013-03-18 | ||||
| 2010-09-30 | $362.00K 10-Q · filed 2011-11-08 | $771.00K derived: sum of 2 quarters · filed 2011-11-08 | $1.22M 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $409.00K 10-Q · filed 2011-08-09 | $861.00K 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $2.20M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |